236 related articles for article (PubMed ID: 27358783)
1. Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience.
Grogan M; Gertz M; McCurdy A; Roeker L; Kyle R; Kushwaha S; Daly R; Dearani J; Rodeheffer R; Frantz R; Lacy M; Hayman S; McGregor C; Edwards B; Dispenzieri A
World J Transplant; 2016 Jun; 6(2):380-8. PubMed ID: 27358783
[TBL] [Abstract][Full Text] [Related]
2. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.
Gray Gilstrap L; Niehaus E; Malhotra R; Ton VK; Watts J; Seldin DC; Madsen JC; Semigran MJ
J Heart Lung Transplant; 2014 Feb; 33(2):149-56. PubMed ID: 24200511
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.
Al Saleh AS; Sidiqi MH; Muchtar E; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Warsame RM; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1520-1525. PubMed ID: 31054986
[TBL] [Abstract][Full Text] [Related]
4. Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis.
Carretero M; Villanueva E; Brulc EB; Faelo FM; Aguirre MA; Pérez-de-Arenaza D; Belziti CA; Arbelbide JA; Nucifora EM; Posadas-Martinez ML
Arch Cardiol Mex; 2023; 93(4):435-441. PubMed ID: 37972368
[TBL] [Abstract][Full Text] [Related]
5. United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis.
Griffin JM; Chiu L; Axsom KM; Bijou R; Clerkin KJ; Colombo P; Cuomo MO; De Los Santos J; Fried JA; Goldsmith J; Habal M; Haythe J; Helmke S; Horn EM; Latif F; Hi Lee S; Lin EF; Naka Y; Raikhelkar J; Restaino S; Sayer GT; Takayama H; Takeda K; Teruya S; Topkara V; Tsai EJ; Uriel N; Yuzefpolskaya M; Farr MA; Maurer MS
Clin Transplant; 2020 Oct; 34(10):e14028. PubMed ID: 32623785
[TBL] [Abstract][Full Text] [Related]
6. Cardiac transplantation outcomes in patients with amyloid cardiomyopathy.
Ohiomoba RO; Youmans QR; Ezema A; Akanyirige P; Anderson AS; Bryant A; Jackson K; Mandieka E; Pham DT; Rich JD; Yancy CW; Okwuosa IS
Am Heart J; 2021 Jun; 236():13-21. PubMed ID: 33621542
[TBL] [Abstract][Full Text] [Related]
7. Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies.
Varr BC; Liedtke M; Arai S; Lafayette RA; Schrier SL; Witteles RM
J Heart Lung Transplant; 2012 Mar; 31(3):325-31. PubMed ID: 22051505
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease.
Abdallah AA; Alapat D; Kaur V; Atrash S
J Oncol Pharm Pract; 2020 Jul; 26(5):1128-1133. PubMed ID: 31795821
[TBL] [Abstract][Full Text] [Related]
9. [Heart transplantation and follow-up treatment with AL-amyloidosis in 5 patients].
Adam Z; Ozábalová E; Němec P; Bedáňová H; Kuman M; Krejčí J; Špinarová L; Žampachová V; Čermáková Z; Pour L; Krejčí M; Sanecká V; Štork M; Pika T; Straub J; Adamová D; Stavařová Y; Král Z; Mayer J
Vnitr Lek; 2018; 64(4):441-449. PubMed ID: 29791180
[TBL] [Abstract][Full Text] [Related]
10. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
[TBL] [Abstract][Full Text] [Related]
12. Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis.
Sidiqi MH; Buadi FK; Dispenzieri A; Warsame R; Lacy MQ; Dingli D; Leung N; Gonsalves WI; Kapoor P; Kourelis TV; Hogan WJ; Kumar SK; Gertz MA
Biol Blood Marrow Transplant; 2019 Mar; 25(3):e108-e111. PubMed ID: 30529461
[TBL] [Abstract][Full Text] [Related]
13. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes and Effectiveness of Heart Transplantation in Patients With Systemic Light-chain Cardiac Amyloidosis.
Jeong H; Hwang I; Kim JH; Cho H; Kim MS; Lee SE; Choi HI; Jung SH; Lee JW; Yun TJ; Park JJ; Kim M; Go H; Park CS; Yoon DH; Kim JJ
Transplantation; 2022 Nov; 106(11):2256-2262. PubMed ID: 35706094
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-term outcomes of heart transplantation for cardiac amyloidosis in the current era.
Vaidya GN; Patel JK; Kittleson M; Chang DH; Kransdorf E; Geft D; Czer L; Vescio R; Esmailian F; Kobashigawa JA
Clin Transplant; 2021 Jun; 35(6):e14308. PubMed ID: 33825224
[TBL] [Abstract][Full Text] [Related]
16. Total Artificial Heart Implantation as a Bridge to Heart Transplantation in an Active Duty Service Member With Amyloid Cardiomyopathy.
Scully MS; Wessman DE; McKee JM; Francisco GM; Nayak KR; Kobashigawa JA
Mil Med; 2017 Mar; 182(3):e1858-e1860. PubMed ID: 28290973
[TBL] [Abstract][Full Text] [Related]
17. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis.
Heybeli C; Bentall A; Wen J; Alexander MP; Buadi FK; Cosio FG; Dean PG; Dispenzieri A; Dingli D; El Ters M; Gertz MA; Hatem A; Kapoor P; Khamash H; Kourelis T; Kumar S; Lorenz EC; Mai M; Muchtar E; Murray DL; Prieto M; Schinstock CA; Stegall MD; Warsame R; Leung N
Kidney Int; 2021 Mar; 99(3):707-715. PubMed ID: 32712168
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status report.
Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar SK; Dingli D; Ansell SM; Gastineau DA; Inwards DJ; Johnston PB; Litzow MR; Micallef IN; Porrata LF; Leung N; Hogan WJ; Buadi FK
Leuk Lymphoma; 2010 Dec; 51(12):2181-7. PubMed ID: 20958232
[TBL] [Abstract][Full Text] [Related]
19. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
[TBL] [Abstract][Full Text] [Related]
20. TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis.
Rosenblum H; Castano A; Alvarez J; Goldsmith J; Helmke S; Maurer MS
Circ Heart Fail; 2018 Apr; 11(4):e004769. PubMed ID: 29615436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
